Shuo Pan

1.0k citations

52 papers · 749 indexed · h-index 17

Impact in

Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Endocrinology, Diabetes and Metabolism top 10%
- Diabetes, Cardiovascular Risks, and Lipoproteins

Papers in ⓘ

Molecular Biology 19
- CRISPR and Genetic Engineering 3
Cardiology and Cardiovascular Medicine 14

Co-authors: Zhongwei Liu (13 shared papers)Bang‐Dang Chen (16 shared papers)Yi‐Ning Yang (12 shared papers)Zhiguo Tang (4 shared papers)Ling Zhu (7 shared papers)Fuqiang Liu (6 shared papers)Xiang Xie (10 shared papers)Qianwei Cui (4 shared papers)
Journals: Lipids in Health and Disease (5 papers)Journal of the American College of Cardiology (3 papers)Oncotarget (2 papers)BMC Cardiovascular Disorders (2 papers)Journal of Hypertension (1 paper)
Partner nations: China Japan United States

In The Last Decade

Shuo Pan

48 papers receiving 742 citations

Peers

Countries citing papers authored by Shuo Pan

Since Specialization

Citations

This map shows the geographic impact of Shuo Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Pan more than expected).

Fields of papers citing papers by Shuo Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Pan. The network helps show where Shuo Pan may publish in the future.

Co-authors

The 25 scholars most cited alongside Shuo Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuo Pan Line = papers co-authored together Shuo Pan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Precise control of SCRaMbLE in synthetic haploid and diploid yeast Nature Communications ·Bin Jia, Yi Wu, Bing‐Zhi Li, Leslie A. Mitchell, Hong Liu, Shuo Pan, Juan Wang, Haoran Zhang, Nan Jia, Bo Li, Michael Shen, Ze‐Xiong Xie, Duo Liu, Ying-Xiu Cao, Xia Li, Xiao Zhou, Hao Qi, Jef D. Boeke, Ying‐Jin Yuan	2018	116
2	Advanced Glycation End Products Induce Atherosclerosis via RAGE/TLR4 Signaling Mediated‐M1 Macrophage Polarization‐Dependent Vascular Smooth Muscle Cell Phenotypic Conversion Oxidative Medicine and Cellular Longevity ·Yujie Xing, Shuo Pan, Ling Zhu, Qianwei Cui, Zhiguo Tang, Zhongwei Liu, Fuqiang Liu	2022	46
3	Probiotic Properties and Cellular Antioxidant Activity of Lactobacillus plantarum MA2 Isolated from Tibetan Kefir Grains Probiotics and Antimicrobial Proteins ·Wei Tang, Chao Li, Zengguo He, Fen Pan, Shuo Pan, Yanping Wang	2017	43
4	Targeting transgene to the heart and liver with AAV9 by different promoters Clinical and Experimental Pharmacology and Physiology ·Bang‐Dang Chen, Chunhui He, Xiaocui Chen, Shuo Pan, Fen Liu, Xiang Ma, Xiao‐Mei Li, Min‐Tao Gai, Jing Tao, Yitong Ma, Yi‐Ning Yang, Xiao‐Ming Gao	2015	42
5	The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China Lipids in Health and Disease ·Jin-Guo Zou, Yi-Tong Ma, Xiang Xie, Yi‐Ning Yang, Shuo Pan, Dilare Adi, Fen Liu, Bang‐Dang Chen	2014	36
6	Hamilton rating scale for depression-24 (HAM-D24) as a novel predictor for diabetic microvascular complications in type 2 diabetes mellitus patients Psychiatry Research ·Shuo Pan, Zhongwei Liu, Shuang Shi, Xun Ma, Wenqian Song, Gongchang Guan, Yong Zhang, Shunming Zhu, Fuqiang Liu, Bo Liu, Zhiguo Tang, Junkui Wang, Ying Lv	2017	34
7	Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population PLoS ONE ·Hongmei Lai, Xiao‐Mei Li, Yi‐Ning Yang, Yitong Ma, Rui‐Hua Xu, Shuo Pan, Hui Zhai, Fen Liu, Bang‐Dang Chen, Qian Zhao	2015	26
8	Endogenous lycopene improves ethanol production under acetic acid stress in Saccharomyces cerevisiae Biotechnology for Biofuels ·Shuo Pan, Bin Jia, Hong Liu, Zhen Wang, Meng‐Zhe Chai, Ming‐Zhu Ding, Xiao Zhou, Xia Li, Chun Li, Bing‐Zhi Li, Ying‐Jin Yuan	2018	25
9	Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives European journal of medical research ·Jing Liu, Shuo Pan, Xiqiang Wang, Zhongwei Liu, Yong Zhang	2023	25
10	−94 ATTG Insertion/Deletion Polymorphism of the NFKB1 Gene Is Associated with Coronary Artery Disease in Han and Uygur Women in China Genetic Testing and Molecular Biomarkers ·Yi‐Ning Yang, Jinyu Zhang, Yi‐Tong Ma, Xiang Xie, Xiaomei Li, Fen Liu, Bang‐Dang Chen, Xing-Hui Dong, Ying‐Ying Zheng, Shuo Pan, Hui Zhai, Dongze Li, Qingjie Chen	2014	23
11	Advanced glycation end products correlate with breast cancer metastasis by activating RAGE/TLR4 signaling BMJ Open Diabetes Research & Care ·Shuo Pan, Yitong Guan, Yanpeng Ma, Qianwei Cui, Zhiguo Tang, Jingyuan Li, Chao Zu, Yong Zhang, Ling Zhu, Jie Jiang, Zhongwei Liu	2022	22
12	Waist-to-Height Ratio and Triglycerides/High-Density Lipoprotein Cholesterol Were the Optimal Predictors of Metabolic Syndrome in Uighur Men and Women in Xinjiang, China Metabolic Syndrome and Related Disorders ·Bang‐Dang Chen, Yining Yang, Yi-Tong Ma, Shuo Pan, Chunhui He, Fen Liu, Xiang Ma, Zhen-Yan Fu, Xiao‐Mei Li, Xiang Xie, Ying‐Ying Zheng	2015	21
13	AGEs exacerbates coronary microvascular dysfunction in NoCAD by activating endoplasmic reticulum stress-mediated PERK signaling pathway Metabolism ·Zhongwei Liu, Haitao Zhu, Yanpeng Ma, Zhiguo Tang, Na Zhao, Yuan Wang, Shuo Pan	2021	20
14	Matrine inhibits advanced glycation end products-induced macrophage M1 polarization by reducing DNMT3a/b-mediated DNA methylation of GPX1 promoter European Journal of Pharmacology ·Qianwei Cui, Haixia Du, Yanpeng Ma, Ting Wang, Haitao Zhu, Ling Zhu, Shuo Pan, Ningbin Min, Xiqiang Wang, Zhongwei Liu	2022	19
15	Optimal cutoff of the triglyceride to high-density lipoprotein cholesterol  ratio to detect cardiovascular risk factors among Han adults in Xinjiang Journal of Health Population and Nutrition ·Huayin Li, Bang‐Dang Chen, Yi-Tong Ma, Yining Yang, Xiang Ma, Fen Liu, Zhen-Yan Fu, Xiang Xie, Xiao‐Mei Li, Shuo Pan, Chunhui He, Ying‐Ying Zheng, Yun Wu, Jing Tao, Chunlan Dong, Tingting Wu	2016	18
16	Apolipoprotein A1 is associated with SYNTAX score in patients with a non-ST segment elevation myocardial infarction Lipids in Health and Disease ·Bang‐Dang Chen, Xiaocui Chen, Yi-Ning Yang, Xiao-Ming Gao, Xiang Ma, Ying Huang, Xiao-Mei Li, Min-Tao Gai, Fen Liu, Shuo Pan, Yi-Tong Ma	2019	18
17	Sfrp1 attenuates TAC-induced cardiac dysfunction by inhibiting Wnt signaling pathway- mediated myocardial apoptosis in mice Lipids in Health and Disease ·Shuo Pan, Xiujuan Zhao, Xu Wang, Xin Tian, Yuanbo Wang, Rong Fan, Na Feng, Shumiao Zhang, Xiaoming Gu, Min Jia, Juan Li, Lu Yang, Kaiyan Wang, Hai-Tao Guo, Jianming Pei	2018	16
18	Association of Egr 3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China Lipids in Health and Disease ·Xia Li, Yitong Ma, Xiang Xie, Yi‐Ning Yang, Xiang Ma, Ying‐Ying Zheng, Shuo Pan, Fen Liu, Bang‐Dang Chen	2014	15
19	Serum uric acid levels are associated with high blood pressure in Chinese children and adolescents aged 10–15 years Journal of Hypertension ·Shuo Pan, Chunhui He, M. Yitong, Yi‐Ning Yang, Xiang Ma, Zhen-Yan Fu, Xiaomei Li, Xiang Xie, Zi-xiang Yu, You Chen, Fen Liu, Bang‐Dang Chen, Tomohiro Nakayama	2014	15
20	Orthogonal Ribosome Biofirewall ACS Synthetic Biology ·Bin Jia, Hao Qi, Bing‐Zhi Li, Shuo Pan, Duo Liu, Hong Liu, Yizhi Cai, Ying‐Jin Yuan	2017	14

About Shuo Pan

Shuo Pan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology, having authored 52 papers that have together received 749 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Advanced Glycation End Products research (7 papers), Hormonal Regulation and Hypertension (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), CRISPR and Genetic Engineering (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Immune cells in cancer (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Clinical Biochemistry (56 citations), Endocrinology, Diabetes and Metabolism (112 citations), Cancer Research (84 citations), Molecular Biology (355 citations) and Cardiology and Cardiovascular Medicine (103 citations). Shuo Pan has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Zhongwei Liu, Bang‐Dang Chen, Yi‐Ning Yang, Zhiguo Tang, Ling Zhu, Fuqiang Liu, Xiang Xie, Qianwei Cui, Yitong Ma and Fen Liu. Their work appears in journals such as Lipids in Health and Disease, Journal of the American College of Cardiology, Oncotarget, BMC Cardiovascular Disorders and Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact